Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Courses Quicksearch

Search Now!


What Have We Learned from Modern Worldwide Registries?

David Badesch


  Sign in to add a review

Leave a Comment

Course ID: 2808

CEU Information


Over the past decade, researchers across the world have performed registry studies with pulmonary hypertension (PH) patients. While the extrapolated data from these studies is limited, the results provide impactful and useful knowledge as it pertains to disease awareness, diagnosis, clinical care, and clinical trial design. This course will examine the information derived from modern global registries and how it has impacted the world of PH.

Course Authors

David Badesch, M.D, FACP
University of Colorado Anschutz Medical Campus
Denver, Colo.

Course Reviewer

George J. Vuturo, Ph.D., RPh
CME/CE Director
Chief Compliance Officer
Planning Committee Member
Professional Education Services Group, LLC, Sterling, VA

Content Reviewer

Janice Agazio, Ph.D., CRNP, RN, FAANP, FAAN
Lead Nurse Planner Planning Committee Member Professional Education Services Group, LLC, Sterling, VA Assistant Dean for Doctoral Programs and Ordinary Professor School of Nursing the Catholic University of America, Washington, DC

CME Reviewer

Danielle Spencer
CME/CE Project Director
Professional Education Services Group, LLC, Sterling, VA

Intended Audience

This continuing education activity provides continuing education (CE) credits for:

  1. Physicians
  2. Nurses
  3. Pharmacists and Pharmacy Technicians
  4. Respiratory Therapists
  5. Social Workers
  6. Other Related Health Professionals

Learning Objectives

At the conclusion of this activity participants should be able to:

  • Enhance knowledge and understanding of recently conducted pulmonary hypertension registries.
  • Review how knowledge of PH has evolved over time as a result of registries conducted in differing time periods and areas of the world.
  • Discuss how knowledge gained from registry studies is impacting future studies of PH.
  • Discuss how knowledge acquired from registries might impact clinical care of patients with pulmonary hypertension
  • Discuss the limitations of data obtained from registries

Release Date

8 March 2017

Expiration Date

31 December 2017

Estimated Time to Complete This Activity

1 hour

Continuing Education Information

This continuing education activity is provided through a joint Providership Agreement between The Pulmonary Hypertension Association (PHA) and Professional Education Services Group (PESG). This activity will provide continuing education for nurses, pharmacists, respiratory therapists, and social workers. All other health care professionals completing this continuing education activity will be issued Certificate of Attendance which may be submitted to accrediting organizations or licensing boards to meet CE requirements.

Accreditation Statement


  • This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of Professional Education Services Group and the Pulmonary Hypertension Association. Professional Education Services Group is accredited by the ACCME to provide continuing medical education for physicians. This activity has been approved for a maximum of 1.0 hours of AMA PRA Category 1 Credits™. Physicians should only claim credit to the extent of their participation.


  • Professional Education Services Group is an accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides a maximum of 1.0 contact hours of nurse CE credit.

Pharmacists and Pharmacy Technicians

  • Professional Education Services Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE UAN 0829-0000-16-180-L04 (Pharmacists) and 0829-0000-16-180-L04 (Pharmacy Technicians). This activity provides 1.0 contact hours (0.10 CEUs) of continuing education credit. There is no cost for this activity. Your record of completion will be reported directly to the CPE Monitor.

Respiratory Therapists

  • The Continuing Respiratory Education (CRCE) system of the American Association for Respiratory Care (AARC) grants approval for 1.0 hours for this course.

Social Workers

  • This program is approved by the National Association of Social Workers for 1.0 Social Work continuing education contact hours.

Instructions for Earning Credit

This activity is a self-study program. In order to claim CE credit, participants must:

View the content, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be directed to the CE processing center at and claim CE credit. Complete a post-test and evaluation online. All evaluation questions must be completed in order to receive a CE credit. Upon successful completion of the post-test and online evaluation form, you can instantly download and/or print your certificate of credit. Your CE records will be stored at for later retrieval at your convenience.

CE Inquiries

For all CE related inquiries, please contact or PHA Online University at (301)-565-3004-x771.

Disclosure Policy

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Professional Educational Services Group (PESG) to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty and planners of this educational activity disclose the following:

David Badesch, M.D., FACP, discloses the following relationships:

  • Actelion Pharmaceuticals UD, Inc.-Advisory Board Member, Steering Committee Member, Grant recipient
  • Gilead Sciences, Inc.-Advisory Board Member, Grant Recipient
  • Bayer HealthCare-Advisory Board Member, Grant Recipient
  • United Therapeutics Corporation- Advisory Board Member, Grant Recipient
  • Lung LLC- Advisory Board Member, Grant Recipient
  • Arena-Grant Recipient
  • Reata-Grant Recipient
  • Bellerophon-Advisory Board Member, Steering Committee Member, Grant recipient,
  • NIH-Grant Recipient


The information presented in this activity reflects the views of the faculty only and not necessarily those of the Pulmonary Hypertension Association (PHA), the sponsors or the educational grant providers. All participants should verify the information and data presented before treating patients or utilizing any therapies noted in these materials. No portion of this activity may be reproduced without the expressed written consent of PHA.

Technical Requirements

This course requires an internet browser. For optimum display, please use Mozilla Firefox, Safari or Google Chrome.

Privacy Policy

For information about PHA's privacy policy, visit

This activity is made possible through unrestricted educational grants to the PHA Medical Education Fund from Actelion Pharmaceuticals, US; Gilead Sciences, Bayer HealthCare, and United Therapeutics.

©2016 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.